Skip to main content

NewAmsterdam Pharma Co N.V.

NAMS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001936258

In the last 90 days, NewAmsterdam Pharma Co N.V. insiders filed 1 open-market purchase and 3 sales; 194 institutions reported holding it in 13F filings for Q2 2026, worth $4.13B in total; 3 superinvestors hold it, including Viking Global Investors and Maverick Capital.

Other share classesNAMSW

13F holders, Q3 2025

Institutional positions in NewAmsterdam Pharma Co N.V. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
137
+6 vs. Q2 2025
Shares held
120.6M
+4.22M (+3.6%) vs. Q2 2025
Total value
$3.43B
+$1.32B (+62.7%) vs. Q2 2025
New holders
21
48 more added
Sold out
15
40 more reduced

Compare with Q2 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting NAMS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2025: 137 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 14 institutionsQ1 2023: 19 institutionsQ2 2023: 29 institutionsQ3 2023: 35 institutionsQ4 2023: 32 institutionsQ1 2024: 76 institutionsQ2 2024: 90 institutionsQ3 2024: 100 institutionsQ4 2024: 131 institutionsQ1 2025: 126 institutionsQ2 2025: 131 institutionsQ3 2025: 137 institutionsQ4 2025: 187 institutionsQ1 2026: 171 institutionsQ2 2026: 194 institutions
Value heldQ3 2025: $3.43B
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $362.2MQ1 2023: $444.9MQ2 2023: $580.6MQ3 2023: $464.1MQ4 2023: $691.4MQ1 2024: $1.71BQ2 2024: $1.38BQ3 2024: $1.28BQ4 2024: $2.53BQ1 2025: $2.28BQ2 2025: $2.11BQ3 2025: $3.43BQ4 2025: $4.19BQ1 2026: $3.96BQ2 2026: $4.13B
Institutions holding NAMS and their total value by quarter
QuarterHoldersValue
Q2 2026194$4.13B
Q1 2026171$3.96B
Q4 2025187$4.19B
Q3 2025137$3.43B
Q2 2025131$2.11B
Q1 2025126$2.28B
Q4 2024131$2.53B
Q3 2024100$1.28B
Q2 202490$1.38B
Q1 202476$1.71B
Q4 202332$691.4M
Q3 202335$464.1M
Q2 202329$580.6M
Q1 202319$444.9M
Q4 202214$362.2M
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q3 2025

Shares, value and share of portfolio for each institution holding NewAmsterdam Pharma Co N.V.; share changes are against Q2 2025.

Institutions holding NAMS in Q3 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Handelsbanken Fonder AB405,800$11.5M0.04%+64,200+18.8%Added
Franklin Resources Inc405,825$11.5M0.00%+71,613+21.4%Added
Bank of America Corp472,100$13.4M0.00%−11,904−2.5%Reduced
Eversept Partners, LP488,592$13.9M1.06%+74,162+17.9%Added
Rock Springs Capital Management LP595,929$16.9M0.99%+59,818+11.2%Added
BlackRock, Inc.622,515$17.7M0.00%+50,842+8.9%Added
American Century Companies Inc624,285$17.8M0.01%+91,369+17.1%Added
Decheng Capital LLC657,051$18.7M3.26%−112,949−14.7%Reduced
Standard Life Aberdeen plc661,946$18.8M0.03%−73,086−9.9%Reduced
First Turn Management, LLC716,971$20.4M3.06%+195,874+37.6%Added
Siren, L.L.C.765,705$21.8M0.85%−428,535−35.9%Reduced
UBS Group AG768,520$21.9M0.00%+140,801+22.4%Added
TimesSquare Capital Management, LLC837,368$23.8M0.34%−35,169−4.0%Reduced
Goldman Sachs Group Inc880,552$25.0M0.00%−69,428−7.3%Reduced
Woodline Partners LP1,157,867$32.9M0.16%−739,330−39.0%Reduced
Pictet Asset Management Holding SA1,292,150$36.7M0.04%−524,575−28.9%Reduced
JPMorgan Chase & Co1,302,498$37.0M0.00%−156,399−10.7%Reduced
Morgan Stanley1,497,479$42.6M0.00%+859,772+134.8%Added
Maverick Capital LtdSuperinvestorMaverick Capital1,504,747$42.8M0.57%−27,127−1.8%Reduced
Duquesne Family Office LLCSuperinvestorDuquesne Family Office1,923,700$54.7M1.39%+1,091,525+131.2%Added
Capital International Investors2,062,535$58.7M0.01%00.0%Unchanged
Janus Henderson Group PLC2,117,075$60.1M0.03%+155,015+7.9%Added
Alliancebernstein L.P.2,141,778$60.9M0.02%−189,805−8.1%Reduced
Cormorant Asset Management, LP2,175,000$61.9M4.27%00.0%Unchanged
Adage Capital Partners GP, L.L.C.2,576,631$73.3M0.12%−436,378−14.5%Reduced
Medicxi Ventures Management (Jersey) Ltd2,869,565$81.6M10.96%00.0%Unchanged
Polar Capital Holdings Plc2,911,634$82.8M0.40%+393,855+15.6%Added
Wellington Management Group LLP4,020,126$114.3M0.02%+697,129+21.0%Added
Jennison Associates LLC4,198,554$119.4M0.07%+1,252,451+42.5%Added
Deerfield Management Company, L.P. (Series C)4,266,693$121.3M1.86%−849,260−16.6%Reduced
FMR LLC5,535,293$157.4M0.01%+3,630,743+190.6%Added
Viking Global Investors LPSuperinvestorViking Global Investors6,475,534$184.2M0.48%−503,000−7.2%Reduced
FCPM III Services B.V.9,212,384$262.0M52.36%−1,419,729−13.4%Reduced
Capital World Investors9,822,711$279.4M0.04%+1,434,986+17.1%Added
Ra Capital Management, L.P.10,138,938$288.4M3.55%00.0%Unchanged
Bain Capital Life Sciences Investors, LLC10,719,110$304.9M20.23%00.0%Unchanged
Frazier Life Sciences Management, L.P.16,701,956$475.0M14.23%+94,882+0.6%Added
UBS Asset Management Americas Inc0$00.00%−320,804−100.0%Sold out
AXA S.A.0$00.00%−242,916−100.0%Sold out
First Trust Advisors LP0$00.00%−131,430−100.0%Sold out
Alps Advisors Inc0$00.00%−60,551−100.0%Sold out
Exome Asset Management LLC0$00.00%−36,574−100.0%Sold out
Two Sigma Investments, LP0$00.00%−28,392−100.0%Sold out
Millennium Management LLC0$00.00%−27,345−100.0%Sold out
HRT Financial LP0$00.00%−26,208−100.0%Sold out
Algert Global LLC0$00.00%−18,140−100.0%Sold out
Prelude Capital Management, LLC0$00.00%−13,420−100.0%Sold out
Hudson Bay Capital Management LP0$00.00%−10,739−100.0%Sold out
Caption Management, LLC0$00.00%−6,000−100.0%Sold out
Kiker Wealth Management, LLC0$00.00%−2,000−100.0%Sold out
Caitong International Asset Management Co., Ltd0$00.00%−595−100.0%Sold out
Raymond James Financial Inc0$00.00%−500−100.0%Sold out